Clinical & Pharma

Vaccine Access Uncertainty Spurs Parental Concern Amid Policy Shifts
Clinical & Pharma Vaccine Access Uncertainty Spurs Parental Concern Amid Policy Shifts

With a detailed understanding of the intersection between policy changes and public health, James Maitland guides us through a crucial conversation about the current challenges facing childhood immunizations. His insights shed light on the evolving landscape of vaccine access amid policy shifts,

Can Tribal Health Officials Close Measles Vaccination Gaps?
Clinical & Pharma Can Tribal Health Officials Close Measles Vaccination Gaps?

With a growing threat posed by the largest measles outbreak since the early '90s, Indigenous communities face distinctive challenges that require targeted efforts and strategic intervention. The vaccination gap in these communities represents not just a health risk but also a significant barrier to

Can TAF1 Unlock New Cancer Therapies Without Harming Blood Cells?
Clinical & Pharma Can TAF1 Unlock New Cancer Therapies Without Harming Blood Cells?

In the quest for effective cancer therapies, scientists at the Sylvester Comprehensive Cancer Center at the University of Miami have embarked on groundbreaking research on the molecule TAF1. This DNA regulatory entity plays a pivotal role in hematopoiesis—the complex process of blood cell formation

Why Are ADHD Prescriptions Soaring in England?
Clinical & Pharma Why Are ADHD Prescriptions Soaring in England?

In England, the landscape of ADHD diagnoses and prescriptions has markedly shifted, reflecting growing awareness and changing societal attitudes toward the condition. Over the decade, ADHD diagnoses have surged as individuals and healthcare systems increasingly recognize the symptoms of this

How Did S. Agona Trigger a 2022 Foodborne Outbreak in China?
Clinical & Pharma How Did S. Agona Trigger a 2022 Foodborne Outbreak in China?

In July 2022, a significant foodborne outbreak occurred in Taiyuan, Shanxi Province, China, posing serious public health challenges and prompting swift investigative efforts. The outbreak was linked to the bacterium Salmonella Agona (S. Agona), known for its potential to cause gastrointestinal

West Pharma Soars Amid GLP-1 Drug Demand; Mixed Market Results
Clinical & Pharma West Pharma Soars Amid GLP-1 Drug Demand; Mixed Market Results

West Pharmaceutical Services has experienced significant financial success, with a notable 23.15% increase in its stock price, reaching $279.26. This surge is primarily driven by a higher-than-expected earnings report, surpassing Wall Street projections and signaling robust demand for its products.

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later